Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results Press Release
DNTH212 (BDCA2 and BAFF/APRIL) Licensing Webcast Oct 16, 2025 8:00 AM EDT Webcast Supporting Materials Licensing of DNTH212 (BDCA2 and BAFF/APRIL) from Leads Biolabs 1.9 MB
